The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Co-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/Infusion

Teva Pharma B.V.PA0749/011/001

Main Information

Trade NameCo-Amoxiclav TEVA 500 mg/100 mg Powder for Solution for Injection/Infusion
Active SubstancesAmoxicillin
Clavulanic acid
Dosage FormPowder for solution for injection/infusion
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/011/001

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor


License statusAuthorised
Licence Issued04/08/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back